LEAH REITZI: Open Payments
NPI 1245777192 · CARLISLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,715 in 82 payments from 28 companies in 2025. Trend: 2023 $5,501 · 2024 $2,507 · 2025 $1,715
Food & beverage: $1,715
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $249 |
| Merck Sharp & Dohme LLC | 7 | $154 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $130 |
| Amgen Inc. | 6 | $121 |
| Tactile Systems Technology Inc | 5 | $116 |
| Actelion Pharmaceuticals US, Inc. | 4 | $102 |
| E.R. Squibb & Sons, L.L.C. | 4 | $95 |
| Esperion Therapeutics, Inc. | 5 | $89 |
| Novo Nordisk Inc | 3 | $71 |
| Abbott Laboratories | 3 | $67 |
Products named: LEQVIO, VERQUVO, JARDIANCE, REPATHA, ELIQUIS, Flexitouch Plus, NEXLETOL, UPTRAVI.
Industry payments across PA — which companies pay providers there.
